PHS
ZEN

PFM Health Sciences’s ZENDESK INC ZEN Stock Holding History

PFM Health Sciences’s Portfolio ZEN Stock Details ZEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-67,034
Closed -$6.9M – 109
2020
Q3 		$6.9M Hold
67,034
– – 0.32% 69
2020
Q2 		$5.93M Buy
+67,034
New +$5.16M 0.31% 70
2018
Q1 		– Sell
-1,336,763
Closed -$45.2M – 104
2017
Q4 		$45.2M Buy
1,336,763
+354,931
+36% +$11.6M 1.07% 39
2017
Q3 		$28.6M Buy
981,832
+431,300
+78% +$12.1M 0.56% 59
2017
Q2 		$15.3M Buy
+550,532
New +$15.1M 0.41% 64

Other funds holding ZEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PFM Health Sciences's ZEN Position: Q4 2020 in Review

PFM Health Sciences sold out of ZENDESK INC (ZEN) in Q4 2020, closing a stake of 67,034 shares — an estimated $6.9M sold.

PFM Health Sciences first reported a position in ZEN in Q2 2017 and held it in 5 quarters. The position peaked at $45.2M in Q4 2017. 473 funds tracked by Wall St. Rank hold ZEN as of Q4 2020.

  • PFM Health Sciences reported no remaining ZENDESK INC position as of Q4 2020 after selling out during the quarter.
  • PFM Health Sciences sold 67,034 ZENDESK INC shares in Q4 2020, an estimated $6.9M.
  • PFM Health Sciences first reported a position in ZENDESK INC in Q2 2017 and held it in 5 quarters.
  • PFM Health Sciences's ZENDESK INC position peaked at $45.2M in Q4 2017.
  • 473 funds tracked by Wall St. Rank held ZENDESK INC as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.